verteporfintertiary university hospitalChronic central serous chorioretinopathy (cCSC)photodynamic therapy
…n = 15; 95% CI: 49.7%–86.3%) achieved fluid reduction following verteporfin PDT. ARs occurred in three patients (6%), with secondary choroi…
3articles mentioning drugs
11drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: verteporfin ×
verteporfin
This drug is selected. Its supporting articles are shown below.
Articles mentioning verteporfin
3 articles · page 1 of 1brolucizumabranibizumabafliberceptfaricimabVerteporfinnAMDNeovascular age-related macular degenerationPubMed
…III randomised controlled trials (RCTs) evaluating ranibizumab, brolucizumab, aflibercept, and faricimab in nAMD. Baseline characteristics i…
97.3%
faricimabbrolucizumabranibizumabafliberceptverteporfinVIEW 1–2MARINAHAWKHARRIER
…ain—ranibizumab, aflibercept (2 mg and 8 mg), brolucizumab, and faricimab—each differing in dosing interval, mechanism, and cost. Compara…